Related Experiment Videos
Excitotoxins and amyotrophic lateral sclerosis
1Neuromuscular Research, Tufts-New England Medical Center, Boston, MA 02111.
Therapie
|May 1, 1990
Summary
The excitotoxin hypothesis suggests that damage to motor neurons in amyotrophic lateral sclerosis (ALS) may be caused by excitatory amino acids (EAA). This theory is supported by experimental models and disordered glutamate metabolism in ALS patients.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
- Emerging evidence implicates excitotoxicity, particularly from excitatory amino acids (EAA), in ALS pathogenesis.
- Disordered glutamate metabolism and EAA involvement in other neurodegenerative diseases support this link.
Purpose of the Study:
- To explore the excitotoxin hypothesis of amyotrophic lateral sclerosis (ALS).
- To review evidence supporting the role of excitatory amino acids (EAA) in motor neuron damage.
- To highlight the therapeutic potential of antiglutamate agents in ALS.
Main Methods:
- Review of experimental models of motor neuron disease induced by excitotoxins (BOAA, BMAA).
- Analysis of evidence for disordered glutamate metabolism in ALS.
- Examination of EAA's role in other neurodegenerative conditions (Huntington's, Alzheimer's).
Main Results:
- Experimental models demonstrate motor neuron damage from excitotoxins.
- ALS patients exhibit evidence of altered glutamate metabolism.
- Excitatory amino acids are implicated in the pathogenesis of other neurological diseases.
Conclusions:
- The excitotoxin hypothesis provides a plausible mechanism for ALS.
- Targeting glutamate pathways with available agents presents a promising therapeutic avenue for ALS.
- Further research into EAA's role is crucial for understanding and treating ALS.